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Besides the well-known inotropic effects of vanadium in cardiac muscle, previous studies have shown
that vanadate can stimulate cell growth or induce cell death. In this work, we studied the toxicity to
neonatal rat ventricular myocytes (cardiomyocytes) of two vanadate solutions containing different
oligovanadates distribution, decavanadate (containing decameric vanadate, V10) and metavanadate
(containing monomeric vanadate and also di-, tetra-, and pentavanadate). Incubation for 24 h with
decavanadate or metavanadate induced necrotic cell death of cardiomyocytes, without significant caspase-3
activation. Only 10 µM total vanadium of either decavanadate (1 µM V10) or metavanadate (10 µM total
vanadium) was needed to produce 50% loss of cell viability after 24 h (assessed with MTT and propidium
iodide assays). Atomic absorption spectroscopy showed that vanadium accumulation in cardiomyocytes
after 24 h was the same when incubation was done with decavanadate or metavanadate. A decrease of
75% of the rate of mitochondrial superoxide anion generation, monitored with dihydroethidium, and a
sustained rise of cytosolic calcium (monitored with Fura-2-loaded cardiomyocytes) was observed after
24 h of incubation of cardiomyocytes with decavanadate or metavanadate concentrations close to those
inducing 50% loss of cell viability produced. In addition, mitochondrial membrane depolarization within
cardiomyocytes, monitored with tetramethylrhodamine ethyl esther or with 3,3′,6,6′-tetrachloro-1,1′,3,3′-
tetraethylbenzimidazolcarbocyanine iodide, were observed after only 6 h of incubation with decavanadate
or metavanadate. The concentration needed for 50% mitochondrial depolarization was 6.5 ( 1 µM total
vanadium for both decavanadate (0.65 µM V10) and metavanadate. In conclusion, mitochondrial membrane
depolarization was an early event in decavanadate- and monovanadate-induced necrotic cell death of
cardiomyocytes.
Introduction
Several studies have reported the ability of inorganic and
organic vanadium compounds to modulate cardiovascular func-
tion and their potential usefulness as protection agents against
ischemia/reperfusion injury in cardiac tissue (1–3). Reports on
the biological effects of vanadate and other vanadium-containing
compounds in heart cells are mainly related to their insulin-
mimetic features (4, 5) and to their ability to increase the
contractile force of heart muscle, that is, their inotropic effect
(6–8). However, several studies have shown vanadate effects
varying from stimulation of cell growth to induction of cell death
(9–14). Moreover, in most cases, the vanadate effect on cell
proliferation was biphasic, being cytotoxic for cells over a
concentration range of 50-100 µM (15). The major aims of
these studies were to analyze vanadate-induced genes expres-
sion, oxidative burst, changes in cytosolic calcium, and cytosk-
eleton alterations without special attention to the effects of
vanadium treatments on cell viability (4, 16–18). Thus, it is
not clear whether these cellular effects are related to vanadate
toxicity. Because of the potential toxic effects of vanadium
compounds, their use as supplements in the diet of athletes is
not recommended (7, 8). However, it should be noted that
vanadium is present in many food products used in a normal
human diet (19, 20), and once incorporated into tissue cells,
vanadium is only very slowly eliminated from mammals, leading
to progressive vanadium accumulation during the life span
(21, 22).
The most widely investigated vanadium compound, vanadate,
is usually reduced to vanadyl (vanadium IV) under physiological
conditions (23). Vanadate seems to be more toxic for living
systems, and its conversion to vanadyl has been proposed as a
detoxification mechanism (24, 25). Because of its anabolic
properties, vanadyl sulfate (VOSO4) has been used by athletes
and body builders to improve performance in weight-training
athletes with neither adverse effects on several blood parameters
nor evidence of its effectiveness (6). However, the ability of
cardiac myocytes to attenuate the toxicity of vanadate by rapidly
reducing vanadate to vanadyl before inducing irreversible effects
remains speculative at present. Willsky and Dosch (26) showed
the relevance of mitochondrial function (oxidative phosphory-
lation) in vanadium metabolism, since yeast respiratory-deficient
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strains accumulated higher amounts of vanadate compounds.
More recently, in previous works (27–30), we have shown that
the mitochondria of liver and heart tissues are the subcellular
organelles with higher contents in vanadium in animals treated
with in-blood injections of monovanadate or decavanadate
solutions.
Different vanadate oligomers can promote different effects
in biological systems in vitro (28, 31–33) and in vivo
(27–31, 34–37). However, it is not clear what the signaling
pathways followed by different oligomeric forms are. The
predominant form of vanadium in biological fluids at pH 4–8
is monomeric vanadate (V1) (38). Higher oligomeric species
of vanadate, although they are not present under physiological
conditions, may be present in toxic vanadium concentrations
or in special cellular compartments where vanadium accumula-
tion takes place. Stankiewicz et al. (39) proposed that decameric
vanadate (V10)1 is the vanadate oligomer with more biochemical
relevance. Several studies have reported that V10 is a more
potent inhibitor of several enzymes than other vanadate oligo-
mers (28). Furthermore, it has been suggested that V10 binding
to specific proteins may prevent its decomposition into smaller
vanadate oligomers (33). However, only a few studies have dealt
in detail with the biological effects of decavanadate solutions
under physiological conditions. In fact, because of its stability
at physiological conditions (27, 28, 30, 35–37), V10 species may
not be completely deoligomerized into other oligovanadates
before inducing changes in several stress markers. Indeed, our
group has demonstrated that V10 induces stronger oxidative
stress effects in the cardiac tissue than monovanadate, depressing
antioxidant enzymes activity and increasing lipid peroxidation
(27, 30, 32, 37). As phosphate analogues (40), vanadate
oligomers have been shown to inhibit and stimulate several
enzyme activities of the phosphate metabolism, such as
ATPases, phosphatases, and kinases (41, 42).
The major aim of the present work is to further explore the
contribution of different vanadate oligomers to cardiac cytotoxic
effects by studying vanadate-induced cell death in neonatal rat
ventricular myocytes. This paper will concentrate on the effects
of different vanadate oligomers (V10 and V1) on cell viability,
vanadium accumulation in cells, intracellular calcium ([Ca2+]i),
reactive oxygen species (ROS) production, and mitochondrial
membrane potential in primary cardiomyocytes in culture. It is
shown that both V10 and V1 induced necrotic cell death in
primary cardiomyocytes in culture.
Experimental Procedures
Primary Cardiomyocyte Cell Culture and Vanadate Treat-
ments. Ventricles from hearts of neonatal (2 days old) Wistar rats
(Rattus norVegicus) were dissociated with pancreatin and collage-
nase. The cell culture protocol used was a modification of the
methods described by Chlopcikova et al. (43). Briefly, the cells
were resuspended in Dulbecco’s modified Eagle’s medium (DMEM)
and medium 199 supplemented with 10% horse serum, 5% fetal
calf serum, 2 mM L-glutamine, 100 U/mL penicillin, and 100 U/mL
streptomycin. To selectively enrich the myocytes, dissociated cells
were preplated for 2 h to allow nonmyocytes to attach to the bottom
of the culture dish. The resultant suspension of myocytes was
transferred onto 1% gelatine-coated 35 mm culture dishes, at a
density of 1 × 106 cells/dish. The mitotic inhibitor cytosine--D-
arabinofuranoside (AraC), in a concentration of 20 µM, was added
during the first 72 h and blocked nonmyocytes cell proliferation.
After 3 days in DMEM growth medium at 37 °C in a humidified
atmosphere with 5% CO2/95% air, the cardiomyocytes were
switched to serum-free medium. Cells were maintained afterward
in serum-free DMEM supplement with 50 U/mL penicillin and 50
U/mL streptomycin and treated with decavanadate (V10) or meta-
vanadate (MV) concentrations ranging from 0 to 50 µM (total
vanadium). All experiments were performed using cardiomyocytes
at 3–4 DIV (days in vitro).
Detection of Vanadate Oligomers and Vanadate Bio-
reduction. The vanadate oligomers present in V10 and MV solutions
used on cardiomyocytes vanadium treatments were measured by
51V nuclear magnetic resonance (NMR) spectroscopy in a Bruker
AM-400 spectrometer at 105.2 MHz equipped with a 5 mm
multinuclear inverse probe, by using a 90° pulse Fourier transform
technique. Spectra were acquired at room temperature using 0.5
mL of vanadate samples in serum-free medium (DMEM) in the
absence and presence of neonatal rat cardiomyocytes, containing
at least 10% D2O, under the following conditions: spectral width,
45455 Hz; acquisition time, 0.05 s; and relaxation delay, 0.01 s.
Chemical shifts reported are relative to an external reference of
VOCl3 (0 ppm). The relative areas of the several free and bound
vanadate resonances were integrated, and the line widths were
obtained after subtracting the value (20 Hz) used in line broadening.
The concentration of vanadate oligomers Vx was calculated from
the fractions of the total integrated areas observed in the recorded
spectra using the following equation: [Vx] ) (Ax/At)·([Vt]/n), where
the symbol A corresponds to the area measured for the x vanadate
species with the n aggregation number (number of vanadium atoms),
At is the sum of measured areas, and [Vt] corresponds to total
vanadate concentration, as described elsewhere (30, 35, 37). The
calculated concentrations of vanadate oligomers were reproducible
within 2–4%. For quantitative measurements, all spectra parameters
were kept constant.
Vanadate reduction products were recorded by electron para-
magnetic resonance (EPR) in a Bruker EMX-300 computerized
spectrometer at 9.654 GHz (X-band) equipped with an Oxford
cryostat (ESR900). The reduced vanadium spectrum in serum-free
DMEM, in the absence or presence of rat cardiac myocytes, was
acquired using 2 mW microwave potency and a 5 Gpp modulation
amplitude. The spectra were recorded at 77 K temperature in 0.2
mL of samples with the typical EPR spectral parameters: receptor
gain, 1.0 × 105; and four scans averaged, as described previously
(37).
Cell Viability. The estimation of viable cells was assessed by
measuring the amount of colored formazan formed upon the
reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) by the mitochondrial dehydrogenase activity present
in live cells, as described previously (44, 45). Formazan was
dissolved in dimethylsulfoxide (DMSO), and the differences in
absorbance between 490 and 700 nm were measured.
Additionally, a direct estimation of viable cardiomyocytes was
obtained through a modified double-staining technique (46). Briefly,
culture medium was discarded, attached cells were washed with
phosphate-buffered saline (PBS), and a stock solution of bisben-
zimide (Hoechts 33258 at 10 mg/mL) was added to dishes, yielding
a final concentration of 0.3 mg/mL in K5 Locke’s buffer, during
30 min at 37 °C. Upon incubation, bisbenzimide was discarded
and the cells were washed with PBS. To the same dishes, a stock
solution of propidium iodide (10 mg/mL) was added, yielding a
final concentration of 10 µg/mL, during the final 5 min of staining.
Bisbenzimide- (stains genetic material) and propidium iodide-
1 AAS, atomic absorption spectroscopy; Ac-DEVD-CHO, caspase-3
substrate; Ac-DEVD-pNA, Ac-DEVD-p-nitroaniline, a specific caspase-3
inhibitor; AraC, cytosine--D-arabinofuranoside; BSA, bovine serum albu-
min; [Ca2+]i, intracellular calcium; DCF, dichlorofluorescein; DHE, dihy-
droethidium; DIV, days in vitro; DMEM, Dulbecco’s modified Eagle’s
medium; DMSO, dimethylsulfoxide; EC, energy charge; EPR, electron
paramagnetic resonance; FITC, fluorescein 5′-isothiocyanate; fura-2 AM,
fura-2-acetoxymethyl ester; H2DCFDA, dichlorodihydrofluorescein diac-
etate; JC-1, 3,3′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine
iodide; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide;
MV, metavanadate solution; MTP, mitochondrial transition pore; TMRE,
tetramethylrhodamine ethyl ester; TORT-2, lobster hepatopancreas marine
reference material for trace metals; V1, monomeric vanadate; V2, dimeric
vanadate; V4, tetrameric vanadate; V5, pentameric vanadate; V10, decameric
vanadate.
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stained (indicates necrotic cells) cultures washed in PBS were
examined and photographed, using a Nikon Diaphot 300 inverted
microscope. Filters for propidium iodide fluorescence used a 550
nm wavelength, and for bisbenzimide, a 420–505 nm wavelength
was used. Vanadate-induced cell death was measured in resus-
pended propidium iodide-stained cells. Propidium iodide fluores-
cence was examined in a fluorimeter using 535 nm excitation and
617 nm emission wavelengths. The fluorescence intensity was
recorded after the addition of 0.1% Tween-20, and at the end, 5
µg/mL of propidium iodide was added as a positive internal standard
control. Fluorescence measurements were carried out with a Perkin-
Elmer 650-40 spectrophotometer, equipped with a thermostatic cell
holder under continuous magnetic stirring.
Caspase-3 Activity and Energy Charge (EC). The caspase-3
activity was measured using Ac-DEVD-p-nitroaniline (Ac-DEVD-
pNA), as described in Samhan-Arias et al. (45). The culture medium
was discarded, attached cells were washed with PBS, and lysates
from two plates were obtained with 50 mM Hepes, pH 7.4, 100
mM NaCl, 0.1 mM EDTA, 5 mM DTT, and 0.1% CHAPS as lysis
buffer. After removal of nonlysed material, caspase-3 activity was
measured in the following buffer: 50 mM Hepes, pH 7.4, 100 mM
NaCl, 1 mM EDTA, 5 mM DTT, 0.1% CHAPS, and 10% glycerol,
and 0.2 mM of caspase-3 substrate (Ac-DEVD-CHO) was added
to the cuvette. The activity was calculated spectrophotometrically
(at 405 nm) using an extinction coefficient for p-nitroaniline of
10500 M-1 cm-1 and with Ac-DEVD-CHO as a specific caspase-3
inhibitor. Caspase-3 human recombinant was used as a positive
control.
EC, a quantitative estimation of the energy status of the cell,
was assessed by determining the in vivo concentration of nucle-
otides. Adenine nucleotides were determined spectrophotometrically
as described in Estabrook et al. (47) after extraction with perchloric
acid (3.3%) and neutralization with KOH (44). The extent of
absorbance was related to that obtained with standard solutions of
ATP, ADP, and AMP, and the concentration of adenine nucleotides
was directly determined. Cell EC was calculated according to the
following equation: (ATP + 0.5ADP)/(ATP + ADP + AMP).
Absorbance measurements were done with spectrophotometers
(Koron, Shimadzu) equipped with thermostatted cell holders.
Cellular Vanadium Uptake. Cellular vanadium uptake was
measured as described previously (29). Briefly, after they were
washed three times with Locke’s buffer, cardiomyocytes were
resuspended and digested with 65% HNO3 at 100 °C. After
digestion, the residue was resuspended with 500 µL of 10% HCl.
The vanadium concentration was determined by atomic absorption
spectroscopy (AAS) using a GBC Avanta atomic absorption
spectrometer, equipped with a GBC GF 3000 graphite furnace
system, with a GBC PAL 3000 autosampler, working at a furnace
program of 63 s with an argon gas flow of 3.0 L/min. The vanadium
lamp was operated at 318.2 nm, with a slit width of 0.2 nm, and
the instrument was calibrated against a series of solutions containing
5, 10, 15, and 20 ppb of vanadium. Calibrating standards were
obtained by successive dilutions of a Merck standard solution of
vanadium 1002 ( 2 mg/L. The detection and quantification limits
of the instrument for these analysis conditions, determined according
ISO 8466-1, were 5 ( 1 and 14 ( 3 ppb, respectively.
The accuracy of the method was determined through analysis of
the certified reference material lobster hepatopancreas marine
reference material for trace metals (TORT-2) (certified vanadium
content 1.64 ( 0.19 mg vanadium/kg). Vanadium recovery ranged
from 92 to 110% of the certified value. Precision was also
acceptable, ranging from 8 to 10%, as percent relative standard
deviation, for this method.
Measurements of Intracellular Ca2+ in Cardiomyocytes.
[Ca2+]i was measured as indicated in previous papers (45, 48, 49).
Briefly, isolated neonatal rat cardiomyocytes were loaded with the
fluorescent indicator, fura-2-acetoxymethyl ester (fura-2 AM) by
incubation in DMEM for 90 min with 5 µg/mL fura-2 AM and
0.025% pluronic-F127 at 37 °C. Afterward, myocytes were washed
twice with K25-Locke’s buffer and the culture dish was placed in
a thermostatic-controlled plate (Warner Instrument Co., Hamden,
CT) of a Nikon Diaphot 300 inverted microscope, equipped with
an epifluorescence attachment and excitation filter wheel. To
measure the [Ca2+]i concentration, ratio fluorescence images were
obtained with excitation filters of 340 and 380 nm and a dichroic
mirror DM510 and absorption filter (emission side) of 510 nm.
Digital images were taken with a Hamamatsu Hisca CCD camera
and Lambda 10-2 filter wheel controller and subsequently analyzed
with the Argus/Hisca software. [Ca2+]i was calculated as described
by Thomas and Delaville (50), with the equation: [Ca2+]i ) Kd·[(R
- Rmin)/(Rmax - R)]·, where R is the measured fluorescence ratio
(340/380) and Rmax and Rmin are the ratio values (340/380) for
Ca2+-bound and Ca2+-free fura-2 in loaded cardiomyocytes. Rmax
and Rmin were experimentally determined from steady-state fluo-
rescence ratio (340/380) measurements after sequential addition to
the culture medium of fura-2-loaded cardiac myocytes of (i)
BrA23187 (5 µg/mL) or ionomycin (45 µg/mL) and (ii) 10 mM
EGTA, respectively. The average values obtained for Rmax and Rmin
were 3.2 ( 0.2 and 0.20 ( 0.02 (n > 500 cells), respectively, and
the obtained average value for the ratio of fluorescence values for
Ca2+-free/Ca2+-bound indicator at 380 nm () was 1.85 ( 0.15.
A value of 224 nM has been used for Kd, the dissociation constant
of the complex fura-2:Ca2+ (50).
Measurement of Intracellular Oxidative Stress. Dichlorodi-
hydrofluorescein diacetate (H2DCFDA) staining was used as a
measure of whole intracellular oxidative stress (51, 52). At three
DIV, cardiomyocytes were switched to K5 Locke’s buffer plus the
indicated additions of vanadate solutions ranging from 0 to 50 µM
total vanadium concentration, and after 12 or 24 h, the cultures
were incubated for 10 min with 10 µM H2DCFDA. The fluores-
cence of H2DCFDA-loaded cells was monitored with a CCD camera
(Hamamatsu), mounted on a Nikon Diaphot 300 inverted micro-
scope using a 470 nm excitation filter and DM510 dichroic mirror
with a 510 emission barrier filter. The exposure time for each
intensity image acquisition was set close to 0.1 s. Acquired images
were analyzed using ARGUS/HiSCA software (Hamamatsu).
Dihydroethidium (DHE) is a specific dye for superoxide anion
(O2-) (53). Cells were treated with vanadate ranging from 0 to 50
µM for 12 or 24 h and loaded with DHE (10 µM final concentration
from a 10 mM stock solution in DMSO) for 10 min at 37 °C in
Locke’s buffer. The harvested cells were washed with PBS twice.
Cell fluorescence images were acquired using the Hamamatsu CCD
camera mounted on the Nikon Diaphot 300 inverted microscope,
with an excitation filter of 470 nm plus a dichroic mirror DM580
and a barrier emission filter of 590 nm, and later analyzed with the
Hamamatsu ARGUS/HiSCA software. The exposure time for each
intensity image acquisition was set close to 0.1 s.
All experiments were performed at 37 °C. The mean fluorescence
intensity was calculated by averaging area intensities from at least
100 cells. For each condition described, images from several fields
of the plates were collected and all of the experiments were done
in triplicate (using three different preparations of cardiomyocytes).
Measurement of ∆ψm with Fluorescent Indicators 3,3′,-
6,6′-Tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine
iodide (JC-1) and Tetramethylrhodamine Ethyl Ester
(TMRE). Mitochondrial membrane potential (∆ψm) was monitored
in cardiomyocytes with either JC-1 or TMRE. Cells were stained
with JC-1 (2 µM) at 37 °C for 30 min and rinsed three times with
PBS solution and changed to K5 Locke’s buffer (54). Cell
fluorescence images were acquired using the Hamamatsu CCD
camera mounted on the Nikon Diaphot 300 inverted microscope
and later analyzed with the Hamamatsu ARGUS/HiSCA software.
The distribution of JC-1 between monomeric and aggregate states
was quantified from green and red fluorescence intensity images
acquired with an excitation filter of 470 nm and a dichroic mirror/
barrier filter setup of 510/520 and 580/590 nm, respectively. All
of the experiments were done in triplicate with at least three
different preparations of cardiomyocytes and different freshly
prepared vanadate solutions, and the results are the average of the
intensity readings obtained for n > 100 cells. The ratios of JC-1
aggregate to monomer intensity for each region were calculated.
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A decrease in this ratio was interpreted as a decrease of ∆ψm,
whereas an increase in the ratio was interpreted as a gain in ∆ψm
(55).
Additionally, ventricular myocytes were loaded with TMRE by
incubation with a solution containing 5 µM TMRE and 0.01%
pluronic-F127 for 15 min. Images were acquired as previously
indicated for the red fluorescence of JC-1 (excitation filter of 470
nm, dichroic mirror of 580 nm, and barrier emission filter of 590
nm). The exposure time for each intensity image acquisition was
set close to 0.1 s.
Protein Concentration and Statistical Analysis. The protein
concentration was determined by the method of Bradford (56) using
the Bio-Rad (Hercules, CA) protein assay reagent and bovine serum
albumin (BSA) as a standard. All data were obtained in at least
three independent experiments with replicates of three or more for
each condition. Results are expressed as means ( standard errors
(SE). Statistical analysis was carried out by a Mann–Whitney
nonparametric test. The significant difference was accepted at the
P < 0.05 level.
Chemicals and Reagents. Ascorbic acid, ATP, BSA, AraC,
DMEM, L-glutamine, medium 199 Hepes modification, heat-
inactivated fetal bovine serum (FBS, Catalog F-9665), heat-
inactivated horse serum (HS, Catalog H-1138), 3-[4,5-dimethylthiazol-
2-yl]-2,5-diphenyltetrazolium bromide (MTT), NADH, NADPH,
pancreatin, and penicillin plus streptomycin were obtained from
Sigma Chemical Co. (St. Louis, MO). An Annexin V-FITC
(fluorescein 5′-isothiocyanate) apoptosis detection kit was purchased
from Sigma Chemical Co. Collagenase type II was from Gibco
(Paisley, United Kingdom). Glucose-6-phosphate dehydrogenase,
glutathione reductase, hexokinase, lactate dehydrogenase, myoki-
nase, and pyruvate kinase were purchased from Roche Molecular
Biochemicals (Mannheim, Germany). Fura-2 AM and pluronic-
F127 were obtained from Molecular Probes (Eugene, OR). 2′,7′-
H2DCFDA was obtained from Molecular Probes (Groningen,
Netherlands). Antibodies against mouse [antimyosin; antimouse
IgG, peroxidase, antimouse HPR; Vimentin Ab-2 (clone V9); goat
antimouse IgG-FITC] were from Santa Cruz Biotechnology (Santa
Cruz, CA). Super Signal chemiluminescent substrate was from
Pierce (Rockford, IL). A caspase-3 activity kit, including caspase-3
human recombinant, was purchased from Calbiochem (San Diego,
CA). TORT-2 (1.64 ( 0.19 mg vanadium/kg) was purchased from
the National Research Council of Canada.
Standard Locke’s buffer contained 154 mM NaCl, 4 mM
NaHCO3, 5 mM KCl, 2.3 mM CaCl2, 1 mM MgCl2, 5 mM glucose,
and 10 mM Hepes (pH 7.4). Other chemicals were of the highest
purity available and purchased from Sigma-Aldrich (St. Louis, MO).
Vanadate Solutions. MV stock solution (50 mM, pH 6.7) was
prepared from ammonium MV (NH4VO3). V10 stock solution was
obtained by adjusting the pH of the former solution to 4.0 (57).
The oligomeric composition of V10 and MV solutions was
determined by 51V NMR spectroscopy in a Bruker AM-400
spectrometer at 105.2 MHz equipped with a 5 mm multinuclear
inverse probe, by using a 90° pulse Fourier transform technique,
as previously reported (29, 30, 35).
Results
Oligomerization State of Vanadate Solutions in DMEM. The
characterization of vanadate solutions in serum-free DMEM was
achieved by 51V NMR spectroscopy, and it was observed that
the spectrum of V10 (5 mM total vanadium) at pH 7.0 contained
mainly decameric species once the three signals from V10 are
observed as follows: V10A at -516 ppm, V10B at -499 ppm,
V10C at -425 ppm, and a very small signal at -560 ppm,
corresponding to V1 (Figure 1A). In contrast, in the MV (5 mM
total vanadium) were detected V1, V2, V4, and also V5 species
at -560, -574, -579, and -587 ppm, respectively (Figure 1B),
as described elsewhere (57). The concentration of each vanadate
oligomer was calculated by integration of the respective areas
of the NMR spectra as a function of total vanadate (see the
equation in the Experimental Procedures), showing clearly
different profiles for V10 and MV solutions (Table 1). The
concentration of V10 increases linearly with the total vanadate
concentration whereas MV does not, as it was previously
reported (33). Different concentrations of V1, V2, V4, and V5
species are present when MV solutions are prepared in serum-
free medium; the higher molecular vanadate oligomers are
favored by increasing the total vanadate concentration, as
described recently for another buffered solution (29). Whereas
5 mM V10 solutions contain about 480 µM V10 (i.e., 4.8 mM
total vanadium as V10) and 0.2 mM V1, 5 mM MV solutions
showed a large contribution of V4 and V2, for example, 1.22
mM V1, 0.706 mM V4, and 0.348 mM V2 (see Table 1), that
is, 2.824 and 0.68 mM total vanadium as V4 and V2, respectively.
Whereas the MV solutions, containing labile oxovanadates
in rapid equilibrium, are stable after dilution in serum-free grow
medium (DMEM), V10 are only moderately stable at physi-
ological pH, due to V10 decomposition, as analyzed by UV–
visible spectroscopy. The decameric species deoligomerization
was assessed by absorption measurements at 400 nm (37 °C)
and followed a first-order kinetic process, with a half-life time
of above 120 min (measured with 1 mM total vanadium
concentration, that is, 100 µM V10 species in DMEM medium)
(not shown). Thus, differential effects of V10 and MV solutions
on cells in DMEM can be unambiguously attributed to V10 only
for incubations up to 2–3 h. After this time period, the V10
solution contains not only V10 species but also the other species
present in MV solutions, in agreement to previous findings in
other buffered solutions (27, 29, 30, 35). Furthermore, it is
known that MV solutions up to 100 µM mostly contain V1, as
described elsewhere (58). Nevertheless, it has been recently
reported that V10 stabilization by cytoskeletal and transmem-
brane proteins can account, at least in part, for V10 effects in
biological systems (33). Therefore, for longer incubations of
cells with V10 solutions, only differential effects observed upon
treatments with V10 vs MV solutions can be taken as an
indication of specific effects of V10.
Purification of Neonatal Cardiomyocytes. The purity of
cardiomyocytes cell cultures (∼80% of myocytes in culture)
Figure 1. 51V NMR spectra of V10 and MV solutions (5 mM total
vanadium) at room temperature. Shown are 105.2 MHz 51V NMR
spectra of V10 (pH 7.0) (A) and MV (pH 7.0) (B) solutions in DMEM.
All spectra were acquired in the presence of 10% D2O. V1 and V2
NMR signals correspond, respectively, to V1 (VO43-, HVO42-, and
H2VO4-) and V2 (HV2O73- and H2V2O72-) species regardless of the
protonation state, whereas V4 and V5 correspond to cyclic V4 (V4O124-)
and V5 (V5O155-) species. V10A, V10B, and V10C are signals of
vanadium atoms from the decameric species.
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was estimated either by cell counting, immunodetection of
myosin heavy chain, or immunostaining (Figure 2). Cardiomyo-
cytes were easily identified microscopically by their character-
istic ability to contract spontaneously and synchronously and
by their morphology: Cultured cardiac cells tend to form a
monolayer, although some myocytes remained isolated when
the cell density in culture plates was too low. Spherical nuclei
were centrally located and surrounded by relatively plentiful
cytoplasm packed with well-delineated myofibrils (59). Con-
taminating fibroblasts, besides immunocytochemical identified
using Vimentin Ab-2 antibody (tested with fibroblasts Swiss
3T3 before use), were readily distinguished by their spindle-
shaped nuclei, as well as by the absence of myofibrils.
Toxicity of Treatments with V10 and MV Solutions To
Cardiomyocytes. The estimation of viable cells upon vanadate
treatments was assessed by MTT viability assay and propidium
iodide fluorescence, as indicated in the Experimental Procedures.
Both vanadate solutions were found to decrease cell viability
(Figure 3). The MTT assay indicated that 24 h of exposure to
V10 and MV solutions induced a similar loss of cell viability
(LD50 ) 10 µM total vanadium) (Figure 3A). It should be noted
that 1 µM V10 corresponds to 10 µM total vanadate, or 50 µM
vanadate in Figure 3A corresponds to 5 µM V10 species. The
slight differences seen in Figure 3A between the loss of cell
Table 1. 51V NMR Spectral Parameters, at Room Temperature, of the Vanadate Species Present in V10 (pH 7) (A) and MV
(pH 7) (B) (5 mM Total Vanadium) in DMEMa
vanadium (5 mM)
V1 V2 V4 V5 V10A V10B V10C
A: V10
δ (ppm) -560.3 -515.5 -498.9 -424.6
ν1/2 (Hz) 168 130 393 431
C (µM) 236 209 189 78
B: MV
δ (ppm) -560.0 -573.8 -578.9 -587.4
∆ν1/2 (Hz) 168 130 55 55
C (µM) 1220 348 706 54
a Listed parameters are chemical shift (δ), half-line width (∆ν1/2), and concentration of the respective vanadate oligomeric species (C). The
concentration (C) of the vanadate species present in V10 and MV was determined from the fractions of the integrated areas observed in the
corresponding spectrum (see the equation in the Experimental Procedures). ∆ν1/2 values have a variation of (20 Hz.
Figure 2. Markers used for the characterization of the cardiomyocytes
culture. Myosin heavy chain (200 kDa) bands detection by immunoblot
in high molecular weight standard marker from Bio-Rad (HMW),
cellular lysates of cardiomyocytes (CM), and cellular lysates of isolated
fibroblasts (FB) (A) and immunodetection of fibroblasts in neonatal
rat primary cardiomyocytes cultures (B). (A) Primary antibody anti-
sarcomeric myosin heavy chain (1/100 dilution) and antimouse IgG
peroxidase (1/10000 dilution) as secondary antibody. (B) B1, B2, and
B3, phase contrast, DAPI staining, and antivimentin staining images,
respectively, of a representative field of the cardiomyocytes preparation.
Staining with antivimentin was performed using 10% goat serum as a
blocking reagent and a Vimentin Ab-2 (clone V9) 1/50 dilution as
primary antibody/goat antimouse IgG-FITC as secondary antibody.
Approximately 80% of the cells identified with nuclear DAPI staining
correspond to cardiomyocytes.
Figure 3. Viability of neonatal rat cardiomyocytes after 24 h of
exposure to vanadate oligomers. After three DIV, cells were treated
with V10 and MV concentrations ranging from 0 to 50 µM total
vanadium and the viability was assessed by MTT assay (A) and
propidium iodide fluorescence (B) (means ( SE). *Significantly
different from control (P < 0.05).
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viability upon 24 h of treatment with V10 and MV solutions
are unlikely to be significant. This conclusion rests not only on
the basis of the statistical analysis of the data (P > 0.05) but
also due to the fact that the loss of cell viability after 12 h of
exposure of cardiomyocytes to V10 and MV solutions was the
same for the same total vanadium concentration.
The staining with Hoescht 33258 showed a great variability
in the DNA amount extracted from vanadate-treated cardiomyo-
cytes (not shown). The observed cell density variability between
vanadate-treated and control dishes was due to the fact that
detached death cells were discarded by washes. For this reason,
all of the subsequent data were analyzed taking into account
the protein content of each culture dish. The loss of viability
monitored by propidium iodide (Figure 3B) pointed out that
V10 and V1 species induced a necrotic cell death. Moreover,
the extent of necrotic cell death monitored by propidium iodide
closely matched the extent of cell viability monitored with the
MTT assay and further reinforced that there are not significant
differences between the extent of cardiomyocytes death induced
by exposure to V10 and MV solutions when they are normalized
to total vanadium concentration.
Although it is known that vanadate treatment in rat cardi-
omyocytes inhibited caspase-3 activation induced by ischemia,
thereby inhibiting apoptosis (60), the possibility of some
contribution of apoptosis to the overall cell death observed in
cardiomyocytes after treatment with V10 and MV solutions
deserved to be considered. The caspase-3 activity was measured
in cardiomyocyte lysates after 3, 6, 9, 12, and 24 h from the
application of 20 µM (total vanadium) V10 or MV. Treatment
of cardiomyocytes with 20 µM total vanadium as V10 or MV
did not elicit an increase of caspase-3 activity with respect to
the very small activity measured for control cardiomyocytes,
that is, 100 ( 30 pmol per min per mg protein (data not shown).
To further assess that the cell death induced by V10 or the other
vanadate species present in MV solutions is not apoptotic cell
death, we carried out double staining of cardiomyocytes with
annexin V-FITC and propidium iodide following the manufac-
turer’s instructions for this standard kit of apoptosis. Fluores-
cence microscopy images of cardiomyocytes were acquired at
6 and 12 h after the addition of 20 µM (total vanadium) V10 or
MV. They confirmed the increase of propidium iodide-stained
cells in this period, as well as cells displaying double staining
of propidium iodide and annexin V-FITC, but not the appearance
of cardiomyocytes positively stained only with annexin V-FITC
(Figure 4A). In contrast, a significant decrease of the cardi-
omyocytes EC was observed after 24 h of exposure to V10: 1
and 2 µM V10 reduced EC by -36 and -39%, respectively.
Slightly lower decreases, -(10–15)% and -(15–20)%, were
measured for 24 h of exposure to the same concentrations of
total vanadium added as MV [thus, cell death monitored by
propidium iodide (Figure 3B)scharacteristic of necrosissand
the decrease of myocytes EC led to the conclusion that the loss
of cell viability observed upon vanadate exposure is largely due
to necrotic cell death].
Vanadium Uptake by Cardiomyocytes. To evaluate if
vanadium uptake by cardiomyocytes depends on the oligomer-
ization state of vanadium, in the present study, we have
quantified vanadium accumulation in cell extracts by AAS. To
this end, after incubation with V10 and MV solutions in
concentrations that produce a significant loss of cardiomyocytes
viability, the extracellular medium was removed and cells were
washed three times with 2 mL of Locke’s K5. Neonatal rat
cardiomyocytes showed a vanadium basal value of 4.341 (
0.297 ppb/mg protein. Vanadium accumulation in cell extracts
seems to increase with total vanadate concentration present in
the growth medium. Treatment with 10 µM (total vanadium)
of V10 and MV solutions for 24 h significantly increased the
content of vanadium up to 45 ( 4 and 60 ( 6 ppb/mg protein,
respectively. These results suggested that the V1 (phosphate
analogue) is taken up by cardiac myocytes. It was also observed
that above 10 µM, vanadium uptake is not dependent on the
oligomerization state of the vanadium solution: 24 h after
treatment, with V10 or MV solutions, cardiomyocytes equally
accumulate both oligovanadates (Figure 5). Treatment with 20
µM vanadate (total vanadium) induces an increase in the
amount of vanadium near +1400%, whereas the vanadium
content in cardiomyocytes treated with 50 µM vanadate is
increased to almost +2000% with respect to control non-
treated cells (Figure 5).
To understand the intracellular uptake and metabolism of
vanadate oligomers by cardiac cells, we used a combination of
EPR spectroscopy with the previous NMR studies. 51V NMR
spectroscopy has provided information about the speciation of
vanadate oligomers in the serum-free culture medium. Looking
Figure 4. Evaluation of vanadate-induced cell death in neonatal rat
cardiomyocytes in culture. (A) Double staining with propidium iodide
and annexin V-FITC of cardiomyocytes treated with 20 µM (total
vanadium) V10 and MV for 6 and 12 h. PhCo, FITC, and P.I. mean
phase contrast microscopy image, annexin V-FITC, and propidium
iodide fluorescence microscopy images, respectively. (B) Decrease of
myocytes EC upon 24 h of treatment with V10 and MV concentrations
ranging from 0 to 20 µM total vanadium (B) (means ( SE).
*Significantly different from control (P < 0.05).
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for a possible vanadium bioreduction in cells, conditioned media
(supernatant) and washed cardiomyocytes were studied by
means of an EPR technique. After 12 h of incubation of
cardiomyocytes with 50 µM (total vanadium) V10 or MV
solutions, EPR signals of reduced vanadium were absent in
either supernatant and washed cell culture (results not shown).
Therefore, although it is known that intracellular vanadate can
be reduced to vanadyl (23), we failed to detect even a weak
vanadyl signal in either supernatant fractions and washed
cardiomyocytes, meaning that reduced vanadium must be below
the detection limit of our EPR instrument, for example, <10
µM reduced vanadium.
Effects of Treatments with V10 and MV on the [Ca2+]i
Homeostasis of Surviving Cardiomyocytes. [Ca2+]i was
measured using cardiomyocytes preloaded with the Ca2+-
sensitive fluorescent dye, fura-2, as described in the Experi-
mental Procedures. Control cardiac myocytes (nontreated cells)
presented a normal low [Ca2+]i in the range of 60 ( 10 nM
and very large intracellular [Ca2+]i peaks associated with
spontaneous beating (Figure 6). Cardiomyocytes treated for 24 h
with V10 or MV (10 µM total vanadium) were able to maintain
its intracellular Ca2+ homeostasis although at higher basal
[Ca2+]i, between 200 and 250 nM, and thus, the height of their
intracellular [Ca2+]i peaks associated with spontaneous beating
is largely reduced when compared with control untreated
cardiomyocytes (Figure 6). Therefore, these results pointed out
that cardiomyocytes exposure to vanadate solutions, either V10
and MV, impaired the balance between calcium uptake and
release by intracellular Ca2+ stores, favoring at least partial
calcium depletion of intracellular stores.
Treatment of Cardiomyocytes with V10 and MV De-
creased Intracellular Oxidative Stress. The intracellular
oxidative stress monitored by DHE was found to be largely
attenuated by exposure of cardiomyocytes to both vanadate
solutions (Figure 7A). DHE has been shown to be more sensitive
to O2•- than to another ROS (53). On average, a 24 h treatment
of cardiomyocytes with 20 µM V10 (i.e., 2 µM V10) or MV
solutions reduced O2•- production by 70 ( 5%, without
significant differences between V10 and MV treatments. It has
been reported that mitochondria play a major role in ROS
production in living cardiomyocytes (61). This was assessed
with our preparations of cardiomyocytes preloaded with H2DCF-
DA as indicated in the Experimental Procedures, a dye that
shows a much lower ROS specificity than DHE (52). The results
obtained with H2DCF-loaded cardiomyocytes demonstrated the
large spatial overlap between the appearance of dichlorofluo-
rescein (DCF) fluorescence and the fluorescence of the mito-
chondrial staining dye JC-1 (Figure 7B), in good agreement with
the results reported with the mitochondrial marker MitoTracker
Red in Swift and Sarvazyan (62). Moreover, treatment of
cardiomyocytes with 5 µM FCCP, which is known to be an
effective agent for depolarizing the mitochondria of cardiomyo-
cytes (63), produced nearly 90% blockade of the oxidation rate
of H2DCF-loaded within cardiomyocytes (data not shown). As
O2•- is the one-electron reduction product of molecular oxygen,
this antioxidant effect of V10 and MV is in agreement with the
inhibition of oxygen consumption by both vanadate solutions
previously reported for cardiac and hepatic mitochondria
(37, 64). A decrease of the amount of O2•- generated will in
turn leads to a decreased production of H2O2, as O2•- can be
considered its metabolic precursor (65).
Figure 5. Vanadium uptake by cultured cardiomyocytes. Vanadium
concentration (ppb V/mg protein) on neonatal rat cardiomyocytes 24 h
after treatment with V10 and MV solutions ranging from 0 to 50 µM
total vanadium (means ( SE). **Significantly different from control
(P < 0.01). *** Significantly different from control (P < 0.001).
Figure 6. Effects of cardiomyocytes exposure to V10 and MV solutions(10 µM total vanadium) on cytosolic Ca2+ homeostasis. In all of the
cases, cardiomyocytes were incubated for 24 h with V10 or MV, then
cardiomyocytes were loaded with Fura-2 AM as indicated in the
Experimental Procedures, changed to K5 Locke’s medium, and
transferred to the thermostatted plate of the Nikon Diaphot 300
epifluorescence microscope. Ratios (340/380) were obtained from
fluorescence images acquired with excitation filters of 340 and 380
nm as indicated in the Experimental Procedures. The results shown
(means ( SE) are the averages of triplicate experiments (n g 20 cells).
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Treatment of Cardiomyocytes with V10 and MV Pro-
duced Mitochondrial Depolarization. Maintenance of the
mitochondrial membrane potential (∆ψm) is essential for the
normal performance and survival of cells with a high metabolic
energy requirement, such as cardiomyocytes. The mitochondrial
membrane potential plays a major role in the modulation of
calcium uptake and release by mitochondria in rat ventricular
myocytes (66). In addition, mitochondria depolarization with
the protonophore FCCP results in a large decrease of ROS
production by cardiomyocytes; see above. In this study, ∆ψm
was initially measured in ventricular myocytes with the fluo-
rescent indicator JC-1. Fluorescence images of cardiomyocytes
stained with JC-1 (Figure 8) showed that control cells exhibited
heterogeneous staining of the cytoplasm with both red (polarized
mitochondria) and green (depolarized mitochondria) fluores-
cence coexisting in the same cell (Figure 8A, top panels).
Consistent with mitochondrial localization, the red fluorescence
was mostly found in rod-shaped and granular structures
distributed throughout the cytoplasm. The green fluorescence
followed a similar pattern but overall gave a more blurred image,
suggesting also some extramitochondrial localization. Super-
imposition of the red and green fluorescence images revealed a
large degree of overlap (orange-yellow color). A minority of
mitochondria, though, exhibited only green fluorescence; these
were most conspicuous in areas of cytoplasm surrounding the
nucleus. Pretreatment of cardiomyocytes with 1 µM V10 (i.e.,
10 µM total vanadium) for 24 h (Figure 8A, bottom panels)
had a dramatic effect on the red fluorescence, which then became
very faint. In contrast, it caused a slight but noticeable increase
in the green fluorescence intensity but did not affect the
distribution substantially. As a result, the superimposed images
showed only a few mitochondria stained with orange, with the
majority exhibiting green or yellow-green fluorescence. Similar
results were obtained with MV solutions, although it required
slightly higher concentrations, 20-50 µM total vanadium (data
not shown).
Because of the large heterogeneity observed in cardiomyo-
cytes stained with JC-1 (Figure 8B), we used TMRE-loaded
cardiomyocytes for a more reliable quantification of V10- and
V1-induced mitochondrial membrane depolarization. TMRE-
loaded cardiomyocytes showed a more homogeneous response
to either V10 or MV solutions (Figure 9A). The dependence of
the average TMRE fluorescence vs the concentration of vanadate
normalized to total vanadium (Figure 9B) clearly showed that
after 24 h of incubation with cardiomyocytes, both V10 and MV
induced a dose-dependent depolarization of mitochondria, with
a similar IC50 value of 6.5 ( 1 µM total vanadium. Figure 9B
also shows that up to 2 µM total vanadium incubation of
cardiomyocytes for 24 h with the vanadate solutions used (MV
and V10) did not produce a significant mitochondria depolar-
ization. Figure 9C shows that a large decrease of the fluores-
cence of TMRE-loaded cardiomyocytes is seen between 6 and
9 h after the application of 20 µM (total vanadium) of V10 and
MV to cardiomyocytes, while only 30% loss of cell viability is
seen after 12 h. The large standard error at 6 h after addition of
V10 and MV is due to the presence of a mixed population of
cells with polarized and completely depolarized mitochondria.
Therefore, a large and sustained vanadate-induced mitochondrial
depolarization precedes the loss of cell viability and the
possibility that this could be mediated by opening of the
mitochondrial transition pore (MTP) deserved to be considered.
However, vanadate-induced depolarization in purified mito-
chondria (37, 64) is not prevented by cyclosporin A (data not
shown). Moreover, the MTP blocker cyclosporin A did not
protect against the loss of cell viability and mitochondrial
depolarization after the treatment of cardiomyocytes with 20
µM (total vanadium) V10 or MV, as this was the same in the
absence and in the presence of the following concentrations of
cyclosporin A: 0.1, 0.5, and 1 µM. Therefore, the possibility
that vanadate-induced mitochondrial depolarization and cell
death can be due to vanadate-induced opening of the MTP is
unlikely.
Discussion
The results reported in this paper clearly show that exposure
to micromolar vanadate solutions can be very harmful to
cardiomyocytes, as only 24 h of incubation of ventricular
neonatal rat myocytes is sufficient to induce cell death with an
IC50 of approximately 10 µM total vanadium. Because 10 mol
of total vanadium contains 1 mol of V10 species, this implies
that only 1 µM V10 is needed to produce nearly 50% cardi-
omyocytes cell death. Furthermore, a noticeable cell death is
already observed after 24 h of incubation with 2 µM total
vanadium, that is, 0.2 µM V10 or 2 µM V1. The exposure of
cardiomyocytes to different oligomeric states of vanadium (from
V1 to V10) was almost equally harmful to these cells, as shown
by the overlap of the dependence of the extent of cell death
attained upon 12 and 24 h of exposure upon the total vanadium
Figure 7. Effect of V10 and MV solutions on the rate of DHE oxidation
by cardiomyocytes. (A) Kinetics of oxidation of DHE by control
cardiomyocytes (squares) and cardiomyocytes incubated 24 h with V10(circles) or MV (up-triangles). Cardiomyocytes were changed to a
prethermostatted K5 Locke’s medium and placed in the plate holder
of the microscope thermostatted at 37 °C, and the kinetics was started
by addition of 10 µM DHE. The kinetic data shown are the average of
triplicate experiments (n g 100 cells, means ( SE). Fluorescence
intensity readings were taken from time-sequential fluorescence intensity
images acquired with a CCD Hamamatsu camera mounted on a Nikon
Diaphot 300 inverted epifluorescence microscope (excitation filter 470
nm; dichroic mirror 580 nm, and emission barrier filter 590 nm) and
analysed with the Argus/Hisca software. (B) Localization of hydrogen
peroxide production in cardiomyocytes labelled with 10 µM H2DCF-
DA (B1) and 2 µM JC-1-stained cells (B2), and merge of the two
previous images highlighted ROS (mostly hydrogen peroxides) produc-
tion in mitochondria (B3).
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concentration added from V10 or MV solutions. Thus, the results
presented in this paper further support the concerns over the
potential risk of the use of vanadium compounds in athletes as
a sport supplement (7, 8) and also for the possible use of these
compounds in the chemotherapy of multidrug-resistant tumors,
as suggested by some authors (67–69). In previous works, we
have reported that the heart is one of the tissues displaying
higher vanadium content after chronic administration of V10 and
MV (29, 30, 32, 34). Because vanadium is slowly eliminated
from mammalian tissues (21, 22), chronic consumption of even
very low doses of vanadium compounds may eventually reach
the toxic levels to cardiomyocytes, and this would elicit a rapid
and irreversible heart damage, which may appear like a “sudden
death” due to heart failure. Because of this, only low vanadium-
containing food products should be allowed for human nutrition
and it is a high-risk practice to use vanadium compounds as a
sport supplement or in therapeutical treatments.
Two different widely used methods, MTT assay and pro-
pidium iodide staining, have been used to assess the loss of
cell viability upon exposure of cardiomyocytes to both V10 and
MV solutions. As propidium iodide staining is a widely accepted
marker for necrotic cell death, this possibility was further
confirmed by the measurement of the decrease of the cellular
EC of cardiomyocytes upon exposure to V10 solutions. The lack
of activation of caspase-3 and of phosphatidylserine external-
ization (monitored with annexin V-FITC) during vanadate-
induced cardiomyocytes cell death pointed out that death through
apoptosis does not afford a significant contribution to this cell
death.
In spite of the very different size of V10 (the predominant
oligomeric vanadium species present in the V10 solutions used
in this study) and V1 (predominant vanadium species in the MV
solutions at the vanadate concentration used in this work), the
amount of vanadium incorporated into these cells was roughly
identical after 24 h of incubation of cardiomyocytes with V10
and MV. Taking into account that no plasma membrane
transport system has been reported yet for V10 and also the half-
life time of approximately 2 h for decomposition of V10 in the
medium used for cardiomyocytes culture (DMEM), the simple
hypothesis to account for similar levels of vanadium uptake by
cardiomyocytes after 24 h of incubation with V10 and MV is
that incorporation of vanadium into the cells takes place by
transport of the less bulky V1 through the plasma membrane,
which is known to permeate through mammalian phosphate
transport systems (23). Although it has been reported that V1
can be reduced to vanadyl inside the cells (23), possibly as part
of a detoxification mechanism (24, 25), EPR measurements done
with the cardiomyocyte cultures used in this study failed to
detect vanadyl, meaning that this specie is below the EPR
detection limit under the experimental conditions used in this
work.
In earlier works, we have shown that vanadium accumulation
in mitochondria is higher than that found in other subcellular
organelles of liver and heart tissues extracted from whole
animals that were injected with V10 or MV solutions (27–30).
Mitochondria are known to also be a major [Ca2+]i store in
cardiomyocytes (76) and also a major compartment for super-
oxide anion and other ROS production in cardiomyocytes (77).
The intracellular pattern of fluorescence staining upon oxidation
of H2DCF within our cardiomyocyte preparations clearly
demonstrated the mitochondrial relevance for ROS production
in our cell cultures because the spatial intracellular regional-
ization of DCF fluorescence staining showed a large overlap
with the spatial intracellular regionalization obtained with the
fluorescence mitochondrial membrane potential probe JC-1. This
is in excellent agreement with Swift and Sarvazyan (62), who
reported that H2DCF is a marker of oxidative stress in cardiac
muscle, which displays a preferential localization of the
fluorescence of oxidized DCF in mitochondria. Superoxide anion
can be considered a side product ROS of mitochondrial
respiration (53), and DHE has been shown to be a good
fluorescence dye to measure the production of superoxide anion
by mitochondria (53). We report herein that the rate of
superoxide anion production within ventricular rat myocytes is
only 30 ( 5% that of control myocytes after 24 h of incubation
of cardiomyocytes with 20 µM (total vanadium) V10 or MV.
This result is highly consistent with the inhibition by both V10
and MV solutions of oxygen consumption in freshly isolated
rat liver and fish heart mitochondria in standard respiration
buffer (37, 64, 78). Although a decrease of ROS production
can be seen as a beneficial effect of vanadate in cardiomyocytes,
inhibition of the mitochondrial respiratory chain can lead to
sustained mitochondrial depolarization, which is lethal for cells
demanding a high supply of metabolic energy, such as cardi-
Figure 8. Effect of V10 and MV solutions on the fluorescence of cardiomyocytes stained with JC-1. (A) Cardiomyocytes were grown on 35 mm
dishes and stained with 0.6 µM JC-1 in the absence (control) and presence of 1 µM V10 (10 µM total vanadium concentration). Left and middle
panels show representative images of the aggregate (red) and monomer (green) fluorescence of the same field, respectively. The right panels show
the merge of the two images; in this case, the yellow/orange-red color denotes colocalization of red and green fluorescence signals. (B) Average
results (means ( SE) of the quantification of pseudocolored pixels in merge images like those shown in panel 8A (n g 100 cells, experiments done
by triplicate). Red pixels were taken for polarized mitochondria, yellow/orange for partially polarized mitochondria, and green pixels for depolarized
mitochondria. *Significantly different from control (P < 0.05).
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omyocytes. Thus, the effect of incubation with V10 or MV
solutions on the mitochondrial membrane potential (∆Ψm) in
cardiomyocytes deserved to be studied.
Both the TMRE and the carbocyanine dye JC-1 have been
shown to monitor the collapse of ∆Ψm in cells in culture
(54, 79). In this work, we show that both TMRE and JC-1 can
be used to monitor vanadate-induced mitochondria depolariza-
tion. On average, the results obtained with TMRE did not show
significant differences between exposure to the same total
vanadium concentration added as V10 or MV. In this study, we
show that a 24 h incubation of cardiomyocytes with V10 and
MV solutions induce the collapse of ∆Ψm, with the same IC50
value of 6.5 ( 1 µM total vanadium (i.e., 0.65 ( 0.1 µM V10
or 6.5 ( 1 µM V1). Therefore, the IC50 value for V10- and MV-
induced mitochondrial membrane depolarization is only slightly
lower than the value obtained for vanadate-induced 50% loss
of cell viability (LD50 ) 10 µM total vanadium). In addition,
depolarization of mitochondria is clearly observed from 6 h after
addition of V10 or MV to cardiomyocytes, and a sustained
collapse of ∆Ψm can be seen after 9 h, whereas only 30 (
10% loss of cell viability is seen after 12 h of treatment with
20 µM (total vanadium) V10 or MV. This is fully consistent
with a leading role of mitochondrial depolarization in vanadate-
induced cardiomyocytes death. In previous works, we have
shown that vanadate can also elicit depolarization of purified
mitochondria (37, 64). The MTP opening is unlikely to be the
molecular event underlying vanadate-induced mitochondrial
depolarization because cyclosporin A, an established MTP
blocker in cardiomyocytes (80), cannot prevent vanadate-
induced depolarization of mitochondria nor vanadate-induced
cardiomyocytes death.
It has been extensively shown that a sustained increase of
cytosolic calcium promotes rapid necrotic cell death in myocytes
through activation of calpains (81). The basal cytosolic Ca2+
of surviving cardiomyocytes, that is, those still showing
spontaneous beating, increased from 60 ( 10 to 200–250 nM
upon 24 h of incubation with 10 µM (total vanadium) V10 or
MV. Because this value is close to the peak cytosolic Ca2+
reached during spontaneous beating in control cardiomyocytes
(250–300 nM), the peak height observed during beating was
largely attenuated in cardiomyocytes incubated with V10 or MV
with respect to control cardiomyocytes. The high sensitivity of
the sarco/endoplasmic Ca2+ pumps to monovanadate is well-
documented, Ki ) 0.5 ( 0.1 µM (70), thus providing a simple
explanation for the sustained rise of basal cytosolic Ca2+
concentration after incubation with vanadate solutions. Also,
these results are in good agreement with earlier studies that have
shown vanadate-induced increased intracellular Ca2+ in cultured
aortic smooth muscle cells, thereby affecting the vascular
tone (71). It has also been reported that vanadate stimulates
the adenylate cyclase activity in many cell types (15, 82). In
the heart, the increased concentrations of 3′-5′-cyclic adenosine
monophosphate (cAMP) cause release of Ca2+ from intracellular
stores, leading to an increase of heart rate and cardiac inotropism
and to vasodilatation (72–75). Furthermore, mitochondrial
membrane depolarization is likely underlying the observed rise
of basal cytosolic calcium and partial depletion of [Ca2+]i stores
upon incubation of cardiomyocytes with V10 or MV solutions,
as mitochondria membrane depolarization leads to mitochondrial
calcium release (83) and also IP3-mediated endoplasmic reticu-
lum release in cardiomyocytes (84). Thus, our results strongly
suggest that mitochondrial membrane depolarization is a key
event in V10- and MV-induced cardiomyocytes death.
In conclusion, exposure to micromolar concentrations of
vanadate (added from V10 or MV solutions) induces cell death
in isolated neonatal rat ventricular myocytes through a similar
toxic pathway, leading to mitochondrial membrane depolariza-
tion and resulting in necrotic cell death.
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